ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,573.66
0.38%
Dow Jones
41,350.93
-0.20%
Gold vs US Dollar
2,944.95
0.24%
Brent Oil
70.365
-0.46%
Bitcoin
83,130.02
-0.66%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biofrontera Inc (BFRIW)

  7. Biofrontera Inc (BFRIW) News

Biofrontera (BFRIW)

Biofrontera Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BFRIW
DateTimeSourceHeadlineSymbolCompany
11/03/202514:00GlobeNewswire Inc.Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025NASDAQ:BFRIWBiofrontera Inc
29/01/202505:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
21/01/202514:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BFRIWBiofrontera Inc
08/01/202514:50GlobeNewswire Inc.Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)NASDAQ:BFRIWBiofrontera Inc
23/12/202414:30GlobeNewswire Inc.Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US MarketNASDAQ:BFRIWBiofrontera Inc
05/12/202413:56Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BFRIWBiofrontera Inc
27/11/202414:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/11/202414:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/11/202414:10GlobeNewswire Inc.Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible NoteNASDAQ:BFRIWBiofrontera Inc
13/11/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
13/11/202422:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BFRIWBiofrontera Inc
13/11/202422:15GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business UpdateNASDAQ:BFRIWBiofrontera Inc
13/11/202419:12Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BFRIWBiofrontera Inc
01/11/202421:28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BFRIWBiofrontera Inc
31/10/202419:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
31/10/202414:32GlobeNewswire Inc.Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)NASDAQ:BFRIWBiofrontera Inc
14/10/202414:30GlobeNewswire Inc.Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)NASDAQ:BFRIWBiofrontera Inc
07/10/202412:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
07/10/202412:45GlobeNewswire Inc.FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One TreatmentNASDAQ:BFRIWBiofrontera Inc
12/09/202413:46Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BFRIWBiofrontera Inc
14/08/202420:30GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
24/06/202412:30GlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIWBiofrontera Inc
14/06/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/05/202420:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
22/05/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
15/05/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
10/05/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
16/12/202213:30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
30/11/202219:08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
28/11/202216:05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRIW

Your Recent History

TG
ISVI
MSCI Brazil
ASX
ALX
Atlas Arteria
ASX
SPL
Starpharma
ASX
MGG
Mogul Games
TG
0N5
Xometry
TG
BRA
Bravura Solutions
AMEX
SPXB
ProShares S&P 500 Bond ETF
TSX
LNR
Linamar
ASI
DPA
FTSE ATHEX Oil and Gas
ASX
OTR
Onterran
TSX
HCAL
Hamilton Enhanced Canadi...
ASX
CCE
Carnegie Clean Energy
NYSE
NM
Navios Maritime
TG
SADC
MSCI China ESG Leaders S...
ASX
GBT
Gbst
TG
VMIG
Vanguard Funds
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads